GDTC · CytoMed Therapeutics Ltd · Insider Trading
Market Cap
$10.40M
Shares
11.93M
Volume · Oct 21
493
Avg daily vol (3M)
81.1K
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-20 | Choo Chee Kong |
Director, 10% Owner |
Buy↑
Filing footnotes — ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED (Direct)
This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made. |
ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED
|
100,000 |
| 2026-07-14 | Choo Chee Kong |
Director, 10% Owner |
Buy↑
Filing footnotes — ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED (Direct)
This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made. |
ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED
|
100,000 |
| 2026-05-13 | Choo Chee Kong |
Director, 10% Owner |
Buy↑
|
Ordinary Shares, no par value per share
|
112,000 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–3 of 3 transactions